Oxford Financial Group LTD Eli Lilly & CO Transaction History

Oxford Financial Group LTD

$1.44 Billion
Q1 2024

A detailed history of Oxford Financial Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Oxford Financial Group LTD holds 352,985 shares of LLY stock, worth $329 Million. This represents 19.08% of its overall portfolio holdings.

Number of Shares

352,985

Previous 376,247 6.18%

Holding current value

$329 Million

Previous $219 Million 25.21%

% of portfolio

19.08%

Previous 16.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $13.8 Million - $18.4 Million	-23,262 Reduced 6.18%	352,985 $275 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $684,322 - $806,726	-1,303 Reduced 0.35%	376,247 $219 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $42.7 Million - $58.9 Million	98,338 Added 35.22%	377,550 $203 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $32 Million - $42.8 Million	91,339 Added 48.62%	279,212 $131 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.31 Million - $1.54 Million	4,212 Added 2.29%	187,873 $64.5 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $525,734 - $612,585	-1,635 Reduced 0.88%	183,661 $67.2 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $3.37 Million - $3.84 Million	11,362 Added 6.53%	185,296 $59.9 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $9,198 - $10,799	33 Added 0.02%	173,934 $56.4 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $8.55 Million - $10.6 Million	-36,432 Reduced 17.32%	173,901 $49.8 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $23,159 - $28,741	103 Added 0.05%	210,333 $58.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $6.44 Million - $7.92 Million	29,060 Added 16.04%	210,230 $48.6 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $1.73 Million - $2.23 Million	-9,564 Reduced 5.01%	181,170 $41.6 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $5.32 Million - $6.89 Million	-32,402 Reduced 14.52%	190,734 $35.6 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $1.94 Million - $2.57 Million	14,896 Added 7.15%	223,136 $37.7 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $2.34 Million - $2.7 Million	15,979 Added 8.31%	208,240 $30.8 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $804,332 - $968,005	-5,896 Reduced 2.98%	192,261 $31.6 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $23.6 Million - $29.2 Million	198,157 New	198,157 $27.5 Million

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.

Account

Oxford Financial Group LTD Eli Lilly & CO Transaction History